CD8[superscript +] T-cell Responses Rapidly Select for Antigen-Negative Tumor Cells in the Prostate
Stimulation of patients' immune systems for the treatment of solid tumors is an emerging therapeutic paradigm. The use of enriched autologous T cells for adoptive cell therapy or vaccination with antigen-loaded dendritic cells have shown clinical efficacy in melanoma and prostate cancer, respec...
Main Authors: | Bak, S. Peter G., Barnkob, Mike Stein, Wittrup, Karl Dane, Chen, Jianzhu |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
American Association for Cancer Research
2014
|
Online Access: | http://hdl.handle.net/1721.1/91603 https://orcid.org/0000-0003-2398-5896 https://orcid.org/0000-0002-5687-6154 |
Similar Items
-
Differential Requirement for CD70 and CD80/CD86 in Dendritic Cellmediated Activation of Tumor Tolerized CD8 T Cells
by: Barnkob, Mike Stein, et al.
Published: (2012) -
Activation of tolerogenic dendritic cells in the tumor draining lymph CD8+ T cells engineered to express CD40 ligand
by: Higham, Eileen M., et al.
Published: (2012) -
Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
by: Higham, Eileen M., et al.
Published: (2012) -
Role of neuropilin-1 in CD8+ T cells
by: Barnkob, M
Published: (2018) -
Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent
by: Olurinde, Mobolaji O., et al.
Published: (2012)